Anti-IFIT2 antibody (ab113112)
Key features and details
- Rabbit polyclonal to IFIT2
- Suitable for: WB
- Reacts with: Human
- Isotype: IgG
Overview
-
Product name
Anti-IFIT2 antibody
See all IFIT2 primary antibodies -
Description
Rabbit polyclonal to IFIT2 -
Host species
Rabbit -
Tested applications
Suitable for: WBmore details -
Species reactivity
Reacts with: Human -
Immunogen
Recombinant fragment, corresponding to amino acids 100-321 of Human IFIT2 (according to GenBank BC032839).
-
Positive control
- WB: Human fetal liver and fetal lung lysates.
-
General notes
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Lyophilized:Reconstitute with 200ul distilled sterile water. Please note that if you receive this product in liquid form it has already been reconstituted as described and no further reconstitution is necessary. -
Storage instructions
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles. -
Storage buffer
pH: 7.20
Preservative: 0.02% Sodium azide
Constituent: 1% BSA -
Concentration information loading...
-
Purity
Immunogen affinity purified -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab113112 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB |
1/1000 - 1/2000. Detects a band of approximately 55 kDa (predicted molecular weight: 55 kDa).
|
Notes |
---|
WB
1/1000 - 1/2000. Detects a band of approximately 55 kDa (predicted molecular weight: 55 kDa). |
Target
-
Sequence similarities
Belongs to the IFIT family.
Contains 6 TPR repeats. - Information by UniProt
-
Database links
- Entrez Gene: 3433 Human
- Omim: 147040 Human
- SwissProt: P09913 Human
- Unigene: 437609 Human
-
Alternative names
- CIG-42 antibody
- cig42 antibody
- G10P2 antibody
see all
Images
Protocols
Datasheets and documents
-
SDS download
-
Datasheet download
References (9)
ab113112 has been referenced in 9 publications.
- Grossegesse M et al. Deep Time Course Proteomics of SARS-CoV- and SARS-CoV-2-Infected Human Lung Epithelial Cells (Calu-3) Reveals Strong Induction of Interferon-Stimulated Gene Expression by SARS-CoV-2 in Contrast to SARS-CoV. J Proteome Res 21:459-469 (2022). PubMed: 34982558
- Chen J et al. STAT1/IFIT2 signaling pathway is involved in PD-L1-mediated epithelial-to-mesenchymal transition in human esophageal cancer. Clin Transl Oncol 24:927-940 (2022). PubMed: 35107757
- Asleh K et al. Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes. Nat Commun 13:896 (2022). PubMed: 35173148
- Filipe IC et al. Comparison of tissue tropism and host response to enteric and respiratory enteroviruses. PLoS Pathog 18:e1010632 (2022). PubMed: 35789345
- Xu B et al. Clinical significance of IFIT2 expression in human renal cancer tissues. Transl Cancer Res 9:3214-3221 (2020). PubMed: 35117687
- Su W et al. Decreased IFIT2 Expression In Human Non-Small-Cell Lung Cancer Tissues Is Associated With Cancer Progression And Poor Survival Of The Patients. Onco Targets Ther 12:8139-8149 (2019). PubMed: 31632065
- Zhao X et al. Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF. Mol Ther 26:755-773 (2018). PubMed: 29398485
- Chen L et al. Decreased IFIT2 Expression Promotes Gastric Cancer Progression and Predicts Poor Prognosis of the Patients. Cell Physiol Biochem 45:15-25 (2018). PubMed: 29316541
- Pinkham C et al. Alterations in the host transcriptome in vitro following Rift Valley fever virus infection. Sci Rep 7:14385 (2017). PubMed: 29085037